SCHEMBL6178010

SCHEMBL6178010

Cc1ccc(S(=O)(=O)N2CCCC2c2cccnc2)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.74
CYP2C19 P33261 1/20 0.74
ALDH1A1 P00352 6/20 0.73
USP2 O75604 1/20 0.73
ADRB2 P07550 3/20 0.67
TSHR P16473 1/20 0.67
MAPT P10636 6/20 0.62
POLB P06746 3/20 0.62
LMNA P02545 3/20 0.62
KMT2A Q03164 1/20 0.59
KDM4E B2RXH2 1/20 0.59
MAPK1 P28482 2/20 0.57
HTT P42858 2/20 0.57
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.56
CHRNA7 P36544 2/20 0.54
CHRNB2 P17787 2/20 0.54
CHRNB4 P30926 2/20 0.54
CHRNA3 P32297 2/20 0.54
CHRNA4 P43681 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11559696 0.93 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL6181813 0.85 TRPA1 (0.60) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL6177618 0.84 PSEN1 (0.69) CYP3A4CYP2C19ALDH1A1USP2TSHR
SCHEMBL6177624 0.84 PSEN1 (0.69) CYP3A4CYP2C19ALDH1A1USP2TSHR
SCHEMBL5307006 0.84 CYP3A4 (0.80) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL396700 0.84 ALDH1A1 (1.00) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL6178012 0.84 CYP3A4 (0.62) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL24016026 0.83 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL24015601 0.83 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2ADRB2
SCHEMBL26465275 0.83 CYP3A4 (0.66) CYP3A4CYP2C19ALDH1A1USP2ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP claimed
EP-1165510-B1 1-ARENESULFONYL-2-ARYL-PYRROLIDINE AND PIPERIDINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2005-09-28 EP disclosed
US-6284785-B1 HAVING ACTIVITY AS LIGANDS OF METABOTROPIC GLUTAMATE RECEPTORS HOFFMANN- LA ROCHE INC. 2001-09-04 US disclosed